Aragão Fábio Farias de, Aragão Pedro Wanderley de, Martins Carlos Alberto de Souza, Salgado Filho Natalino, Barroqueiro Elizabeth de Souza Barcelos
Sociedade Brasileira de Anestesiologia, Brasil; Universidade Federal do Maranhão (UFMA), São Luís, MA, Brasil.
Universidade Federal do Maranhão (UFMA), São Luís, MA, Brasil.
Rev Bras Anestesiol. 2014 Sep-Oct;64(5):299-306. doi: 10.1016/j.bjan.2013.07.014. Epub 2014 May 14.
Maternal hypotension is a common complication after spinal anesthesia for cesarean section, with deleterious effects on the fetus and mother. Among the strategies aimed at minimizing the effects of hypotension, vasopressor administration is the most efficient. The aim of this study was to compare the efficacy of phenylephrine, metaraminol, and ephedrine in the prevention and treatment of hypotension after spinal anesthesia for cesarean section. Ninety pregnant women, not in labor, undergoing cesarean section were randomized into three groups to receive a bolus followed by continuous infusion of vasopressor as follows: phenylephrine group (50μg+50μg/min); metaraminol group (0.25mg+0.25mg/min); ephedrine group (4mg+4mg/min). Infusion dose was doubled when systolic blood pressure decreased to 80% of baseline and a bolus was given when systolic blood pressure decreased below 80%. The infusion dose was divided in half when systolic blood pressure increased to 120% and was stopped when it became higher. The incidence of hypotension, nausea and vomiting, reactive hypertension, bradycardia, tachycardia, Apgar scores, and arterial cord blood gases were assessed at the 1st and 5th minutes. There was no difference in the incidence of hypotension, bradycardia, reactive hypertension, infusion discontinuation, atropine administration or Apgar scores. Rescue boluses were higher only in the ephedrine group compared to metaraminol group. The incidence of nausea and vomiting and fetal acidosis were greater in the ephedrine group. The three drugs were effective in preventing hypotension; however, fetal effects were more frequent in the ephedrine group, although transient.
产妇低血压是剖宫产脊髓麻醉后常见的并发症,对胎儿和母亲均有不良影响。在旨在将低血压影响降至最低的策略中,使用血管升压药最为有效。本研究的目的是比较去氧肾上腺素、间羟胺和麻黄碱在预防和治疗剖宫产脊髓麻醉后低血压方面的疗效。90例未临产的剖宫产孕妇被随机分为三组,接受静脉推注后持续输注血管升压药,具体如下:去氧肾上腺素组(50μg+50μg/分钟);间羟胺组(0.25mg+0.25mg/分钟);麻黄碱组(4mg+4mg/分钟)。当收缩压降至基线的80%时,输注剂量加倍;当收缩压降至80%以下时,给予静脉推注。当收缩压升至120%时,输注剂量减半;当收缩压更高时,停止输注。在第1分钟和第5分钟评估低血压、恶心和呕吐、反应性高血压、心动过缓、心动过速、阿氏评分和脐动脉血气的发生率。低血压、心动过缓、反应性高血压、输注停止、阿托品使用或阿氏评分的发生率无差异。与间羟胺组相比,仅麻黄碱组的抢救推注量更高。麻黄碱组恶心和呕吐以及胎儿酸中毒的发生率更高。这三种药物在预防低血压方面均有效;然而,麻黄碱组对胎儿的影响更频繁,尽管是短暂的。